Jefferies Downgrades L3Harris Technologies Stock to Hold
- Reports
- 3
- Developments
- 1
- Repetition
- 67%
New informationRepeats or wire copies
What happened
Jefferies Financial Group lowered L3Harris Technologies from a "buy" rating to a "hold" rating and set a $315.00 target price in a report issued on August 26th. Argus also downgraded L3Harris Technologies from a "buy" to a "hold" rating.
From dailypolitical.com
Why it matters
Analyst reports, including the downgrade by Jefferies Financial Group, influence L3Harris Technologies' market valuation. The company currently maintains a consensus rating of "Moderate Buy" with an average target price of $355.92.
From dailypolitical.com
Who's involved
- L3Harris TechnologiesCompany subject to the stock rating downgrade
- Jefferies Financial GroupFinancial services company that issued the downgrade
Who could feel it
Possible knock-on effectsThese are possibilities Brind reasoned out, not predictions, and not advice. Most are not stated in any report.
- Manufacturers Life Insurance CompanySpeculative
Manufacturers Life Insurance Company might see the market price of L3Harris Technologies stock lower, potentially reducing the worth of its financial stake.
Keep exploring
The entities involved
-
L3Harris Technologies
company in Melbourne, United States
Nothing else this week.
-
Jefferies Financial Group
American financial services company
-
MarketBeat
American personal finance blog
Related events
- MarketBeat reported average stock ratings while Jefferies Financial Group reiterated a buy rating for Sequoia Economic Infrastructure Inc.
- Jefferies Financial Group reaffirmed a Buy rating on London Stock Exchange Group.
- Cantor Fitzgerald and Jefferies Financial Group downgraded EyePoint Pharmaceuticals' stock rating from overweight/buy to neutral/hold on October 19, 2026.
- Jefferies Financial Group changed its stock rating for BioLife Solutions, Inc. on October 12, 2026.
- Jefferies Financial Group upgraded Flowco shares to buy rating on August 11, 2026.